Walgreens settles Medicaid violation accusations

RIVIERA BEACH, FL - OCTOBER 25: A sign is seen outside a Walgreens store as the company announced it's quarterly profits beat expectations on October 25, 2017 in Riviera Beach, Florida. The company reported that fourth quarter earnings were $1.31 per share which beat Wall Street estimates of $1.21. (Photo by Joe Raedle/Getty Images)

MILWAUKEE — The U.S. Attorney in the Eastern District of Wisconsin says Walgreens has agreed to pay $3.5 million to settle allegations that it failed to comply with Medicaid rules designed to ensure that stimulant medications are dispensed for appropriate medical treatment.

The Wisconsin Medicaid program reimburses a pharmacy for dispensing certain stimulant medications only if it first verifies that a physician prescribed the stimulant for medically appropriate treatment, such as attention deficient disorder.

Federal and state authorities allege that from 2011 through 2014, Walgreens violated Wisconsin Medicaid rules by routinely dispensing stimulant medications to Wisconsin Medicaid beneficiaries without that verification in violation of the False Claims Act.

Walgreens operates retail pharmacies throughout Wisconsin.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.